Clincosm LogoSign in Get a demo

carcinoid tumors

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

Active, not recruiting
  • Carcinoid Tumors
  • Boston, Massachusetts
  • +1 more
Apr 14, 2022

Neuroendocrine Tumors, Carcinoid Tumors Trial in Stanford, Tampa (Pasireotide Long Acting Release (LAR))

Active, not recruiting
Has Results
  • Neuroendocrine Tumors
  • Carcinoid Tumors
  • Pasireotide Long Acting Release (LAR)
  • Stanford, California
  • +1 more
Jan 11, 2022

Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)

Completed
Has Results
  • Neuroendocrine Tumors
  • +3 more
  • 68Ga-DOTATOC PET/CT
  • Iowa City, Iowa
    University of Iowa Health Care
Jul 24, 2021

Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)

Completed
Has Results
  • Neuroendocrine Tumors
  • +3 more
  • 68Ga-DOTATOC PET/CT
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Dec 17, 2020

Carcinoid Tumors, Pancreatic NET Trial in Tampa (Ibrutinib)

Completed
Has Results
  • Carcinoid Tumors
  • Pancreatic NET
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 9, 2020

Neuroendocrine Tumor, Paraganglioma, Carcinoid Tumors Trial in San Francisco (Computed Tomography (CT), Gallium Ga

Terminated
Has Results
  • Neuroendocrine Tumor
  • +3 more
  • Computed Tomography (CT)
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Oct 21, 2019

Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (90Y-DOTA-tyr3-Octreotide, Dosimetry-Guided Peptide

Unknown status
  • Neuroendocrine Tumors
  • +3 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Apr 25, 2019

Carcinoid Tumors, Neuroendocrine Tumors Trial in London (5-Hydroxy-Tryptamine)

Terminated
  • Carcinoid Tumors
  • Neuroendocrine Tumors
  • London, Ontario, Canada
    St. Joseph's Health Care
Apr 11, 2018

Carcinoid Tumors, Islet Cell (Pancreatic NET), Other Neuroendocrine Tumors Trial in Stanford (68Ga-DOTA TATE)

No longer available
  • Carcinoid Tumors
  • +2 more
  • 68Ga-DOTA TATE
  • Stanford, California
    Stanford University, School of Medicine
Aug 21, 2017

Neuroendocrine Tumors, Carcinoid Tumors Trial in New York (68Ga-DOTATOC PET)

Terminated
  • Neuroendocrine Tumors
  • Carcinoid Tumors
  • 68Ga-DOTATOC PET
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 1, 2017

Neuroendocrine Tumors, Carcinoid Tumors, Adrenal Gland Tumors Trial in Stanford (pertuzumab, erlotinib)

Terminated
Has Results
  • Neuroendocrine Tumors
  • +5 more
  • Stanford, California
    Stanford University School of Medicine
Jan 12, 2017

Carcinoid Tumors Trial in Belgium, France (Lanreotide, Placebo (for sunitinib), Sunitinib)

Unknown status
  • Carcinoid Tumors
  • Brussels, Belgium
  • +19 more
Jan 30, 2017

Melanoma, Soft Tissue Sarcoma, Parathyroid Carcinoma Trial in Lebanon, Richmond (Dacarbazine and bortezomib)

Completed
  • Melanoma
  • +4 more
  • Dacarbazine and bortezomib
  • Lebanon, New Hampshire
  • +1 more
Aug 17, 2016

Carcinoid Tumors Trial in United States (Pasireotide (SOM230))

Completed
Has Results
  • Carcinoid Tumors
  • Pasireotide (SOM230)
  • Los Angeles, California
  • +3 more
May 29, 2012

Pheochromocytoma, Neuroblastoma, Paraganglioma Trial in Vancouver (123I-meta-iodobenzylguanidine)

Unknown status
  • Pheochromocytoma
  • +4 more
  • Vancouver, British Columbia, Canada
    Vancouver Coastal Health
Jun 13, 2011